)%5 &rqvxphu 0hgld &rqihuhqfh. riley... · 0dnh jrrg 1r frpsurplvh 2xu lqjuhglhqwv duh...
TRANSCRIPT
B. Riley FBR Consumer & Media Conference
October 3, 2019
Cautionary Notes
2
Cautionary Notes
FORWARD-LOOKING STATEMENTS
This presentation and oral statements accompanying this presentation contain forward-looking statements, andany statements other than statements of historical fact could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events, such as expected revenue,gross margin and EBITDA in 2019 and beyond, including related growth rates, the anticipated development, scalingand commercialization of Amyris’s product pipeline and introduction of new products, including HMOs, vitamins andcannabinoid ingredients, including the cost and purity of such products, expected growth of Amyris’s Clean Beauty, babyskincare, Sweetener and F&F businesses, the anticipated size and growth of the global beauty and personal care market,expected distribution channels for Amyris’s baby skincare products, the anticipated size, growth and composition of theglobal baby care market, the expected size, growth and composition of the global psychoactive market and the U.S. andglobal cannabinoid markets, anticipated sources of liquidity and improvements to Amyris’s capital structure and balancesheet, and expectations regarding Amyris’s financial and operational results and ability to achieve its business plan in 2019and beyond. These statements are based on management’s current expectations and actual results and future events maydiffer materially due to risks and uncertainties, including risks related to Amyris’s liquidity and ability to fund operating andcapital expenses, risks related to potential delays or failures in development, production and commercialization of products,risks related to Amyris's reliance on third parties, and other risks detailed from time to time in filings Amyris makes with theSecurities and Exchange Commission, including Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q andCurrent Reports on Form 8-K. Amyris disclaims any obligation to update information contained in these forward-lookingstatements, whether as a result of new information, future events, or otherwise.
Copyright © 2019 Amyris, Inc. All rights reserved
Making the
World Healthier Make good. No compromise.®
3Copyright © 2019 Amyris, Inc. All rights reserved
© 2019 Amyris, Inc. All Rights Reserved.
Consumers are Demanding Sustainability
“The Flavor & Fragrance industry is experiencing an increasing need for natural ingredients,” says Julia Raquet, who heads BASF’s Aroma Ingredients business. “But
fluctuating product quality, availability and sustainability are constant challenges for our customers. By entering the market with biotechnology-based aroma ingredients,
we intend to provide our customers with high-quality products to respond to the current market challenges.”*
“BASF is known for its high-quality standards, traceability and excellent regulatory know-how,” says ToineJanssen, founder of Isobionics. “By combining our biotech-based product portfolio and strong development
pipeline with BASF’s expertise and its global market reach, we can provide the natural aroma ingredients market with even more innovations – and boost our growth.”*
*Source: BASF News Release, September 2019
4
FERMENTATION MAKES NATURAL
SUSTAINABLE
Copyright © 2019 Amyris, Inc. All rights reserved 5
Growing market size demand of squalane (CAGR** 10%)
Full Year 2018:Neossance™ market share** = >40%
OLIVE squalane
NEOSSANCEsqualane (sugar)
Our squalane has offset the demand of 4M sharks*
Highest purity & most sustainable squalane
87-92%94-95%PURITY
Before & After Amyris: The Squalane Evolution
* The demand of 4M sharks harvested for shark squalane ** CAGR is based on Allied Market Research for squalene market*** Purity data from Aprinnova technical team
6Copyright © 2019 Amyris, Inc. All rights reserved
BisabololRenewably sourcedwith a reduced ecological footprint
230x less land to produce the same quantity
Hectares to produce 1 ton
Sugarcane.Candeia Tree.
12 years to grow each tree
1 year to grow and harvest
Source: Givaudan Active Beauty, Bisabolife® brochure
Before & After Amyris: Disrupting the Fragrance Industry
7
© 2019 Amyris, Inc. All rights reserved.
Amyris is Delivering on the Promise of Synthetic Biology
1 Engineer microbial factories
Emeryville, CA, USA(near San Francisco)
2Produce ingredients using our industrial fermentation technology
Brotas, BrazilCMOs
3Commercialize through collaboration partners and direct to consumer
8
#1 Synthetic Biotechnology
Platform
Fully integrated production of high
value products
Proven Commercial Platform
Ingredients Consumer
Partners Consumer Brands
Market Leadership
Making Health and Beauty Sustainable
• HMOs
• Vitamins
• Cannabinoids
• Rose, Inc.
• Clean Beauty
• Health & Wellness
• F&F Ingredients
Disruptive Pipeline
9Copyright © 2019 Amyris, Inc. All rights reserved
$0$20$40$60$80
$100$120$140
Skincare Hair Care ColourCosmetics
Men'sGrooming
Fragrances Oral Care Bath andShower
Deodorants Sets/Kits Baby andchild-specific
Products
Sun Care Depilatories
10*Source: Euromonitor 2017, **Source: Research and Markets.com, 2019 Copyright © 2019 Amyris, Inc. All rights reserved
Beauty & Personal Care
Beauty & Personal Care Global Market Sizes by Health & Personal Care category* (2017, $B)
This Market is Expected to Surpass $716B by 2025**
= markets Amyris participates in
4%6%
2%5%
3%6%
5%6%
3%6%
3%5%
2%6%
4%8%
5%6%
2%6%
3%5%
1%4%
2015-2017 2017-2021E
CAGR
© 2019 Amyris, Inc.. Confidential & Proprietary.© 2019 Amyris, Inc.. Confidential & Proprietary.
© 2019 Amyris, Inc.. Confidential & Proprietary.© 2019 Amyris, Inc.. Confidential & Proprietary.
© 2019 Amyris, Inc.. Confidential & Proprietary.© 2019 Amyris, Inc.. Confidential & Proprietary.13
© 2019 Amyris, Inc.. Confidential & Proprietary.© 2019 Amyris, Inc.. Confidential & Proprietary.14
© 2019 Amyris, Inc.. Confidential & Proprietary.© 2019 Amyris, Inc.. Confidential & Proprietary.15
© 2019 Amyris, Inc.. Confidential & Proprietary.© 2019 Amyris, Inc.. Confidential & Proprietary.
© 2019 Amyris, Inc.. Confidential & Proprietary.© 2019 Amyris, Inc.. Confidential & Proprietary.17
© 2019 Amyris, Inc.. Confidential & Proprietary.© 2019 Amyris, Inc.. Confidential & Proprietary.
Launched September 4, 2019
18
19
Clean, Sustainable
Re
tail
Pri
ce
(by
mL
)
20
21
© 2019 Amyris, Inc.. Confidential & Proprietary.© 2019 Amyris, Inc.. Confidential & Proprietary.22
© 2019 Amyris, Inc.. Confidential & Proprietary.© 2019 Amyris, Inc.. Confidential & Proprietary.23
© 2019 Amyris, Inc.. Confidential & Proprietary.© 2019 Amyris, Inc.. Confidential & Proprietary.24
Addressing global problems:Diabetes Obesity
Meeting Millennial demands:All-Natural Zero CaloriesNon GMO
AMYRIS SWEETENER IS THE RIGHT SOLUTION AND AT THE RIGHT TIME
© 2019 Amyris, Inc.. Confidential & Proprietary.© 2019 Amyris, Inc.. Confidential & Proprietary.25
AMYRIS IS DISRUPTING THE SWEEETNER MARKETSWEETNESS EQUIVALENCY
350-500 grams of sugar* 1 gram of
YTD sales is offsetting ~20B calories from sugar
*depending on application
© 2019 Amyris, Inc.. Confidential & Proprietary.© 2019 Amyris, Inc.. Confidential & Proprietary.
MILLIONS OF MILLENNIALS SAID…….We believe in doing
I Love Sugar
Sugar Is An Addiction
Sugar is Linked to Diabetes
Use with Moderation
26
© 2019 Amyris, Inc.. Confidential & Proprietary.© 2019 Amyris, Inc.. Confidential & Proprietary.
SWEET FOR ME. SWEET FOR THE PLANET.100 % SWEET
0 bitter aftertaste
0 glycemic index
0 calories
0 GMO
fermented for a healthy gut
100% SUSTAINABLE
responsibly grown sugarcane
10x less farmland to produce
1 clean fermentation process
all recycled cane-based packaging
0 waste (almost, we’re working on it)
2727
© 2019 Amyris, Inc. All rights reserved. 28
Cannabinoids:
Our Next MegaMarket
Source: Yoga Journal
© 2019 Amyris, Inc. All rights reserved.
Cannabinoids – The New Legal Psychoactive Opportunity
Legal Cannabis Global Spending Forecastd (US$)
By 2025: $66B2019-2025 CAGRe: 24%
Common Legal Psychoactive Markets(Global Demand US$)
Are Cannabinoids the next mega market?
Future Growth CAGR
Alcohola By 2026: $1,864B
2017-2026:4%
Tobaccob By 2026: $1,012B
2019-2026:5%
Coffeec By 2024: $15B
2018-2024:6%
Sources: PR Newswire, Market Watch, Allied Market, Statista, Grand View Research 29
© 2019 Amyris, Inc. All rights reserved.
Our Cannabinoid Opportunity
1) Supplier of choice for global brands
2) Clean ingredient for our beauty brands
3) Build leading over-the-counter brand for pain, anxiety and sleep supplement - a leader in sustainable health
30
© 2019 Amyris, Inc. All rights reserved.
Breakout opportunity in fermentation - derived cannabinoids
Source: Paradigm Capital Inc.
Outdoor Grow Indoor Grow Biosynthesis
~CAPEX >$10 Million > $30 Million $4.5 Million
Cycle times 4-6 months 3-4 months Semi-continuous
~COGS ($/kg) $3,000-5,000 $5,000-$10,000 $500-$1,500
• $300M cannabinoids collaboration with LAVVAN; expect to commercialize CBD in 2020.• Capable of developing CBD and other cannabinoids at significant cost advantage with
ultra purity, which is essential for brand adoption in this market.
Copyright © 2019 Amyris, Inc. All rights reserved31
Advantaged Portfolio Delivers Strong Growth & Expanding Profitability
2018 20192017* Adjusted for loss making product sales on contracts and one time revenues
Gross Margin % 49% 52% 55%- 65%
32
ProductLicense/Royalties/Collab
Product CAGR = 98%
Copyright © 2019 Amyris, Inc. All rights reserved
*Excludes Vitamin E and one time Licenses 33 Copyright © 2019 Amyris, Inc. All rights reserved
Collaborations %
Products %
Percentage of Total Dollar Contribution from Gross Margin to cover Operating Expenses
Actual Plan
$0
$EBITDA
$M
Revenue Mix shifting to Recurring and Delivering a Sustainable Business
Our Platform is Delivering
Branded Product Sales +190%
Ingredient Sales +65%
2017-2019 REVENUE CAGR*
Copyright © 2019 Amyris, Inc. All rights reserved34
SqualaneHemisqualane
Derived Fragrances
Farnesene* Derivatives
Fermented* Products
RebM
BisabololOther Fragrances
* Excludes discontinued products and Vitamin E
Copyright © 2019 Amyris, Inc. All rights reserved
© 2019 Amyris, Inc. All Rights Reserved.
Evaluating the Competitive Landscape
*Total equity capital investments do not include any debt instrumentsSources: Forbes, Business Wire, PR Newswire, Industry Expert Source, SF Business Times, Tech Crunch
Market Cap / Valuation
Total Equity Capital
Invested
2019Annual
Revenue
Annual Growth Rate (2018-2019)
Products Commercialized
at Industrial Scale
Commercial Visibility
Amyris $490M ~$1B* $150M(fcst) 134% 9
Gingko $4B(est) $719M $80M(est) 100% 2(est)
Zymergen $1B+(est) $574M N/A N/A N/A
35
© 2019 Amyris, Inc. All rights reserved.
Warrants are a strong source of cash from long term investors
85%
12%
3%
103M62M
16M
10M
Warrants Held by Insiders vs. Others103M Total Shares Issued
191M Fully Diluted88M Reserved for Issuance
Insider Warrants
Others
Not likely to be exercised/converted
Total Outstanding Shares
Reserved for Employee-Related Plans
Reserved for warrants/convertible notes/preferred stock (excluding amount not likely to be exercised/converted)
Amount not likely to be exercised/converted
36Copyright © 2019 Amyris, Inc. All rights reserved
Notes:•Estimated warrant exercise potential proceeds of up to $212M subject to certain conditions•$64M expected to convert into equity by end of 2019: (Foris $51.5M, Schottenfeld $12.5M) - equivalent to approximate 20M warrants converting into shares
Make good.No compromise.
• Our ingredients are inside over $7B of consumer retail purchases sold through 3,000 of the world’s leading personal care and beauty brands
• Our Biossance Skin Care Brand is the fastest growing Skin Care Brand in North America
• We have the leading product in the natural Sweetener market. We are committed to a healthier planet and a sweet life for all!
• Most profitable & fastest growing product portfolio in the industry
Good for People
Good for the Planet
Good for Business
™
37Copyright © 2019 Amyris, Inc. All rights reserved
© 2019 Amyris, Inc. All rights reserved.